Skip to main content
Caplight Logo









p53-Therapeutics, Inc.

p53-Therapeutics, Inc.

Private
United StatesHealthcare & Life Scienceshttps://p53-therapeutics.com/

Company Overview

p53-Therapeutics, Inc. is a biotechnology company developing a new class of small molecule cancer therapeutics to effectively bypass mutations in the p53 tumor suppressor gene.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small molecule therapeuticsp53 pathwayprecision oncologydrug discoverytumor suppressorcancer drug developmentbiotech startuponcology researchdrug resistancetherapeutic candidateprecision medicinetargeted therapybiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

p53-Therapeutics, Inc. Comparables

Compare p53-Therapeutics, Inc. with similar companies based on industry and business-model similarity.

p53-Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nutshell Therapeutics
84%
PMV Pharma
82%
Frontier Medicines
79%
View all Comparables

p53-Therapeutics, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

p53-Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

p53-Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about p53-Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States
Employee Range2
Year Founded2013
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?